RYH:ARCA-Guggenheim S&P 500 Equal Weight Healthcare (USD)

ETF | Health | NYSE Arca

Last Closing

USD 30.25

Change

0.00 (0.00)%

Market Cap

USD 0.47B

Volume

0.11M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks to replicate as closely as possible, before fees and expenses, the performance of the S&P 500? Equal Weight Index Health Care Total Return. The underlying index is an unmanaged equal weighted version of the S&P 500? Health Care Index that consists of the common stocks of the following industries: health care equipment and supplies, health care providers and services, and biotechnology and pharmaceuticals that comprise the Health Care sector of the S&P 500? Index. The fund is non-diversified.

Inception Date: 01/11/2006

Primary Benchmark: S&P 500 Equal Weighted HC TR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 0.4%

Management Expense Ratio: 0.40 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
3020-OL:HK X DBMSCIUSA 1.72 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-15 )

Largest Industry Peers for Health

Symbol Name Mer Price(Change) Market Cap
XLV Health Care Select Sector SPDR.. 0.13 %

+0.47 (+0.34%)

USD 37.76B
VHT Vanguard Health Care Index Fun.. 0.10 %

+1.22 (+0.48%)

USD 16.98B
XBI SPDR® S&P Biotech ETF 0.35 %

+2.03 (+2.43%)

USD 7.05B
IHI iShares U.S. Medical Devices E.. 0.43 %

+0.30 (+0.54%)

USD 5.55B
IXJ iShares Global Healthcare ETF 0.46 %

+0.35 (+0.39%)

USD 4.11B
IYH iShares U.S. Healthcare ETF 0.43 %

+0.25 (+0.43%)

USD 3.23B
FHLC Fidelity® MSCI Health Care In.. 0.08 %

+0.25 (+0.38%)

USD 2.94B
FXH First Trust Health Care AlphaD.. 0.63 %

+1.10 (+1.07%)

USD 1.33B
FBT First Trust NYSE Arca Biotechn.. 0.57 %

+2.10 (+1.46%)

USD 1.08B
IHF iShares U.S. Healthcare Provid.. 0.43 %

+0.14 (+0.27%)

USD 0.82B

ETFs Containing RYH

QRH:CA 0.00 % 1.20 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.58% 77% C+ 58% F
Dividend Return 0.15% 38% F 6% D-
Total Return 1.73% 77% C+ 54% F
Trailing 12 Months  
Capital Gain 1.04% 59% D- 46% F
Dividend Return 0.65% 42% F 6% D-
Total Return 1.69% 55% F 36% F
Trailing 5 Years  
Capital Gain 63.43% 95% A 79% B-
Dividend Return 3.04% 47% F 9% A-
Total Return 66.46% 85% B 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 9.80% 82% B 71% C-
Dividend Return 10.21% 73% C 66% D+
Total Return 0.40% 50% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 15.63% 64% D 67% D+
Risk Adjusted Return 65.31% 68% D+ 88% B+
Market Capitalization 0.47B 59% D- 55% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.